Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma

被引：0
|
作者：
Igde, M. [1 ]
Kabasakal, H. [2 ]
Ozturk, O. [3 ]
Karatekin, G. [4 ]
Aygun, C. [5 ]
机构：
[1] Samsun Educ & Res Hosp, Div Allergy & Immunol, Dept Pediat, Samsun, Turkey
[2] Samsun Educ & Res Hosp, Pediat, Samsun, Turkey
[3] Atakum Community Hlth Ctr, Samsun, Turkey
[4] Zeynep Kamil Matern & Childrens Training & Res Ho, Div Neonatol, Dept Pediat, Istanbul, Turkey
[5] 19 Mayis Univ, Fac Med, Dept Pediat, Div Neonatol, Samsun, Turkey
来源：
ALLERGY | 2016年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1174
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [1] Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma
    Igde, Mahir
    Kabasakal, Hilal
    Ozturk, Onur
    Karatekin, Guner
    Aygun, Canan
    [J]. MINERVA PEDIATRICA, 2018, 70 (03) : 252 - 259
  • [2] Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing
    Simoes, Eric A. F.
    Groothuis, Jessil R.
    Carbonell-Estrany, Xavier
    Reger, Christian H. L.
    Mitchell, Ian
    Fredrick, Linda M.
    Kimpen, Jan L. L.
    [J]. JOURNAL OF PEDIATRICS, 2007, 151 (01): : 34 - 42
  • [3] Respiratory syncytial virus: Early palivizumab prophylaxis in the NICU
    Bonaparte, J
    Wu, SY
    Pyati, S
    Wilks, A
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 270A - 270A
  • [4] Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
    Gortner, Ludwig
    [J]. KLINISCHE PADIATRIE, 2017, 229 (05): : 259 - 260
  • [5] Palivizumab prophylaxis for respiratory syncytial virus in Canada:: utilization and outcomes
    Oh, PI
    Lanctôt, KL
    Yoon, A
    Lee, DSC
    Paes, BA
    Simmons, BS
    Parison, D
    Manzi, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 512 - 518
  • [6] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Mahadevia, Parthiv J.
    Malinoski, Frank J.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 519 - 520
  • [7] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Reeve, Carole A.
    Whitehall, John S.
    Buettner, Petra G.
    Norton, Robert
    Reeve, David M.
    Francis, Fleur
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (05) : 253 - 258
  • [8] Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab
    Wang, Daniel Y.
    Saleem, Mahwesh
    Paes, Bosco A.
    Mitchell, Ian
    Li, Abby
    Lanctot, Krista L.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (08) : 775 - 780
  • [9] Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
    Lina Bollani
    Eugenio Baraldi
    Gaetano Chirico
    Andrea Dotta
    Marcello Lanari
    Antonello Del Vecchio
    Paolo Manzoni
    Antonio Boldrini
    Piermichele Paolillo
    Sandra Di Fabio
    Luigi Orfeo
    Mauro Stronati
    Costantino Romagnoli
    [J]. Italian Journal of Pediatrics, 41
  • [10] Effectiveness of Palivizumab in Respiratory Syncytial Virus Prophylaxis in Children with Cystic Fibrosis
    Winterstein, Almut G.
    Eworuke, Efe
    Xu, Dandan
    Schuler, Pamela
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 148 - 148
12345